Phenacemide
From Wikipedia, the free encyclopedia
|
Phenacemide
|
|
| Systematic (IUPAC) name | |
| N-carbamoyl-2-phenyl-acetamide | |
| Identifiers | |
| CAS number | |
| ATC code | N03 |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C9H10N2O2 |
| Mol. mass | 178.188 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | 22-25 hours. |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Phenacemide is an anticonvulsant of the urea class.
[edit] External links
- DDB 34078
- MedlinePlus DrugInfo uspdi-202454
- Coker S (1986). "The use of phenacemide for intractable partial complex epilepsy in children". Pediatr Neurol 2 (4): 230–2. doi:. PMID 3508693.
- Coker S, Holmes E, Egel R (1987). "Phenacemide therapy of complex partial epilepsy in children: determination of plasma drug concentrations". Neurology 37 (12): 1861–6. PMID 3683877.

